Upcoming Webinars for Dementia and Alzheimer’s Researchers

Neuromodulatory Subcortical Systems PIA: Updates in Orexinergic, Cholinergic and Noradrenergic Systems in AD and Related Conditions

Jan. 25, 2021
10 a.m. CST

Neurotransmitters synthesized in subcortical nuclei, including norepinephrine, serotonin, acetylcholine and orexin regulate most brain functions. These neuromodulatory subcortical systems become dysfunctional already in the first stages of Alzheimer’s disease. Yet, we still know little about the NSS in AD and AD-related disorders. Come to learn, discuss and contribute to this webinar that brings the latest developments on the NSS in AD.

Panelists:
Claudio Linguori, Daniel Ferreira Padilla and Lotta Granholm-Bentley

The Eye as a Biomarker for AD PIA: Year in Review

Jan. 25, 2021
1:30 p.m. CST

Femke H. Bouwman will outline and summarize 2020's most impactful findings in retinal biomarker development in AD. Jessica Alber will discuss up and coming developments for 2021, as well as the PIA5's goals to chart a path forward towards retinal biomarker validation in AD. Following these presentations, there will be a group discussion led by the PIA Executive Committee. Moderated by Victoria Pelak and Robert Rissman.

Panelists:
Femke H. Bouwman and Jessical Alber

From PIs to Participants: Moving Toward Sustainable Representation in Clinical Trials in ADRD

Jan. 26, 2021
11 a.m. CST

This webinar, hosted by the Clinical Trials Advancement and Methods PIA and the Diversity and Disparities PIA, will address both long-term and short-term solutions to disparities and diversity in the context of ADRD clinical trials. Moderated by Erin Abner and Ganesh Babulal.

Panelists:
Neelum Aggarwal, Joshua Grill and Jonathan Jackson

Perioperative, Cognition and Delirium PIA: Year in Review

Jan. 26, 2021
3 p.m. CST

This PIA is founded in the concept that anesthesia and surgery represent a physiological stress that, in a vulnerable brain, may produce delirium and accelerated cognitive decline. COVID-19 might be doing the same, and this webinar will, in three brief expert presentations, review remote cognitive testing paradigms and existing data linking COVID-19 and altered cognitive states.

Chicken, Egg or Both: Progress in Understanding the Association Between Sleep and Circadian Rhythm Disruption and Alzheimer's Disease in 2020

Jan. 27, 2021
2:30 p.m. CST

This webinar will highlight epidemiological and mechanistic studies from the past year linking sleep disruption to Alzheimer's Disease and shedding light on the potentially bidirectional nature of these links.

Presenter:
Andrew Lim

Atypical Alzheimer's Disease PIA: Year in Review

Jan. 29, 2021
9 a.m. CST

Dr. Keir Yong, Alzheimer's Society Fellow, Dementia Research Centre, University College London, will consider 2020 advances in our understanding of atypical Alzheimer’s disease. Key themes will be discussed regarding canonical atypical clinical phenotypes of AD and atypicality based on neuropathology, neuroimaging and molecular biomarker studies. Predictions for 2021 will be made regarding atypical AD research and wider implications regarding phenotypic heterogeneity across the AD spectrum.

Guide to AAIC 2021: Reviewing

Feb. 2, 2021
9 a.m. CST

Join ISTAART for a free webinar featuring a step-by-step guide to reviewing abstracts; an overview of logistics; and expert insight from Eric Siemers; theme lead for Drug Development, AAIC 2021 Scientific Program Committee.

ISTAART Journal Club Meet the Author

Feb. 4, 2021
11 a.m. CST

João Pedro Ferrari Souza will lead a conversation with Renaud La Joie and Gil Rabinovici about the paper, Prospective Longitudinal Atrophy in Alzheimer’s Disease Correlates with the Intensity and Topography of Baseline Tau-PET, published in Science Translational Medicine. Hosted by the Neuroimaging PIA.

Maura Malpetti will lead a conversation with Leonardo Iaccarino and Gil Rabinovici about the paper, Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults with Cognitive Impairment, published in JAMA.